<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04470206</url>
  </required_header>
  <id_info>
    <org_study_id>2020_0080</org_study_id>
    <nct_id>NCT04470206</nct_id>
  </id_info>
  <brief_title>Spinal Cord Stimulation for Neuropathic Pain Relief : Efficacy Study Using the Specific NPSI Questionnaire (NPSI)</brief_title>
  <acronym>NPSI</acronym>
  <official_title>Spinal Cord Stimulation for Neuropathic Pain Relief : Efficacy Study Using the Specific NPSI Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several studies have shown the efficacy of spinal cord stimulation in reducing the intensity&#xD;
      of neuropathic pain. This efficacy is defined as obtaining relief of at least 50% of the&#xD;
      preoperative pain intensity assessed by the visual analog scale or the digital pain scale. No&#xD;
      study has evaluated the efficacy of stimulation specifically on the different components of&#xD;
      neuropathic pain, only an overall improvement in pain has been described.&#xD;
&#xD;
      A specific questionnaire for neuropathic pain has been extensively validated in neuropathic&#xD;
      pain: the Neuropathic Pain Symptom Inventory (NPSI).&#xD;
&#xD;
      Thanks to the multidimensional structure of this questionnaire, investigators propose to&#xD;
      evaluate separately and in a much more specific way the efficacy of spinal cord stimulation&#xD;
      in the short and long term on the different components of neuropathic pain and to define&#xD;
      responders subgroups.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2020</start_date>
  <completion_date type="Anticipated">December 19, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 19, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of spinal cord stimulation on the various symptoms of neuropathic pain using the Neuropathic Pain Symptom Inventory (NPSI), change is being assessed.</measure>
    <time_frame>Day 0; Day 7 after surgery; 3 months, 6 months and 12 months after surgery</time_frame>
    <description>Neuropathic pain score obtained by the NPSI questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy of spinal cord stimulation on the psychological level (anxiety and depression)</measure>
    <time_frame>Day 0 and 12 months after surgery</time_frame>
    <description>Anxiety and depression score assessed by Hospital Anxiety and Depression (HAD) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Efficacy of spinal cord stimulation on quality of life.</measure>
    <time_frame>Day 0 and 12 months after surgery</time_frame>
    <description>Quality of life score assessed by EQ-5D questionnaire</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Neuropathic Pain</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with neuropathic pain following surgery or in the context of a complex regional&#xD;
        pain syndrome and requiring spinal cord stimulation in the neurosurgery department of Foch&#xD;
        Hospital.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  With neuropathic pain:&#xD;
&#xD;
               -  confirmed (DN4 score&gt; 4/10)&#xD;
&#xD;
               -  going back to one year at least&#xD;
&#xD;
               -  refractory to well-conducted medical treatments&#xD;
&#xD;
          -  Requiring spinal cord stimulation: the indication is validated by the&#xD;
             multidisciplinary meeting (RCP Neuromodulation / Pain at Foch Hospital)&#xD;
&#xD;
          -  Having given his non-opposition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with sepsis&#xD;
&#xD;
          -  Having no well-conducted prior medical treatment&#xD;
&#xD;
          -  With uncontrolled psychiatric disorders (active psychosis, suicidal disorders, severe&#xD;
             depression)&#xD;
&#xD;
          -  with somatoform disorders&#xD;
&#xD;
          -  addicted to alcohol or drugs or withdrawal syndrome&#xD;
&#xD;
          -  Deprived of liberty or under guardianship.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Naoufel Ouerchefani, MD</last_name>
    <phone>01 46 25 35 33</phone>
    <phone_ext>0033</phone_ext>
    <email>n.ouerchefani@hopital-foch.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Foch</name>
      <address>
        <city>Suresnes</city>
        <state>Ile De France</state>
        <zip>92500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naoufel Ouerchefani, MD</last_name>
      <phone>0033 1 46 25 35 33</phone>
      <email>n.ouerchefani@hopital-foch.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 8, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2020</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuropathic pain</keyword>
  <keyword>NPSI</keyword>
  <keyword>Spinal Cord Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

